Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
UKCCCR trial to study the effect on breast cancer mortality of annual mammographic screening starting at age 40
Source of recordUK Trials
ISRCTNISRCTN24647151
Date ISRCTN assigned06/04/2000
Local reference number(s)G9000793
Public titleUKCCCR trial to study the effect on breast cancer mortality of annual mammographic screening starting at age 40
Scientific title
AcronymThe 'Age' trial
Disease/condition/study domainBreast cancer
Study hypothesisTo determine the effectiveness of mammographic screening starting at age 40, compared with starting at age 50, in reducing mortality from breast cancer.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaWomen aged 40-41 identified from HA registers
Participants - exclusion criteriaWomen under care for breast cancer may be removed from the prior notification list by the GPs prior to randomisation
Patient information material
Anticipated start date30/07/1990
Anticipated end date31/12/2010
Status of trialOngoing
Target number of participants160,000
InterventionsWomen in the intervention group are offered annual screening by mammography until the year of their 48th birthday. Screening is by 2-view mammography at 1st screen and single view subsequently. All women in both intervention and control groups will be invited for screening in the NHSBSP between the age of 50-52.
Primary outcome measure(s)Deaths from breast cancer in women free of the disease at trial entry in the two groups. Information on prognostic factors of all breast cancers is also collected.
Secondary outcome measure(s)Not provided at time of registration
PublicationsResults: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17161727

Protocol: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids= 10572845

Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids= 11979379
Sources of fundingMedical Research Council (UK)
Sponsor nameMedical Research Council (UK)
Sponsor details20 Park Crescent
London
United Kingdom
W1B 1AL
Sponsor telephone+44 (0)20 7636 5422
Sponsor fax+44 (0)20 7436 6179
Sponsor emailclinical.trial@headoffice.mrc.ac.uk
Sponsor websitehttp://www.mrc.ac.uk
Contact nameDr SM Moss
Contact detailsCancer Screening Evaluation Unit
Institute of Cancer Research
Section of Epidemiology
D Block Cotswold Road
Sutton Surrey
United Kingdom
SM2 5NG
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN24647151
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central